tailieunhanh - Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry

Plan a financial strategy before you enter law school. If possible, pay off any outstanding consumer debt. Save as much money as you can to reduce the amount you will borrow. Have a plan for meeting the expenses of your legal education and anticipate what portion of the plan will be based on borrowing. It is also important that you have a good credit history. Because most of your financial aid is likely to come from loans, you are likely to graduate from law school with debt to repay. Currently, the average law school debt is about $100,000. Keep accurate records of all loans you receive during your enrollment in law. | Regular Article Psychotherapy and Psychosomatics Psychother Psychosom 2006 75 154-160 DOI 000091772 Financial Ties between DSM-IV Panel Members and the Pharmaceutical Industry Lisa Cosgrove a Sheldon Krimsky b Manisha Vijayaraghavan a Lisa Schneider a a University of Massachusetts Boston Mass. and b Tufts University Medford Mass. USA Key Words Conflicts of interest Ethics Financial interests Psychopharmacologics Abstract Background Increasing attention has been given to the transparency of potential conflicts of interest in clinical medicine and biomedical sciences particularly in journal publishing and science advisory panels. The authors examined the degree and type of financial ties to the pharmaceutical industry of panel members responsible for revisions of the Diagnostic and Statistical Manual of Mental Disorders DSM . Methods By using multimodal screening techniques the authors investigated the financial ties to the pharmaceutical industry of 170 panel members who contributed to the diagnostic criteria produced for the DSM-IV and the DSM-IV-TR. Results Of the 170 DSM panel members 95 56 had one or more financial associations with companies in the pharmaceutical industry. One hundred percent of the members of the panels on Mood Disorders and Schizophrenia and Other Psychotic Disorders had financial ties to drug companies. The leading categories of financial interest held by panel members were research funding 42 consultan cies 22 and speakers bureau 16 . Conclusions Our inquiry into the relationships between DSM panel members and the pharmaceutical industry demonstrates that there are strong financial ties between the industry and those who are responsible for developing and modifying the diagnostic criteria for mental illness. The connections are especially strong in those diagnostic areas where drugs are the first line of treatment for mental disorders. Full disclosure by DSM panel members of their financial relationships with for-profit entities .